 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: December 2025
Volume 10 | Issue 12
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 10
Issue Published : 115
Article Submitted : 19455
Article Published : 8041
Total Authors : 21252
Total Reviewer : 769
Total Countries : 144
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Novel Purification Process Of Omalizumab Biosimilar For Industrial Production |
| Authors Name: | Om Narayan , Tarun Gupta, Mayank kumar Thakkar, Rupen Bhavsar , Kishor Galani, Sudharti Gupta, Kaushal Joshi , Hetal Katrodiya, Shalini Sharma, Vivek Dave , Anuj Kumar, Divya Tailwani, Chandramauli Rawal |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_187128
|
| Published Paper Id: | IJRTI2306007 |
| Published In: | Volume 8 Issue 6, June-2023 |
| DOI: | |
| Abstract: | Omalizumab is an Anti-IgE monoclonal antibody used to treat allergic asthma, nasal polyps, urticaria and allergic rhinitis. Omalizumab is a recombinant DNA-derived humanized IgGl monoclonal antibody that selectively binds to human immunoglobulin (IgE). The antibody has a molecular weight of approximately 149 kD. With increase in demand of medication and advancement in the upstream processes, the production of monoclonal antibodies increased from milligram per litre to grams per litre. The substantial increase in the upstream productivity creates pressure to deliver highly purified drug product, resulting in development of efficient and robust separation processes for purification of these monoclonal antibodies In this study, the impurities such as size variants as well as charge variants are separated from the protein mixture through chromatographic techniques to obtain a purified antibody composition which is pharmaceutically acceptable and substantially free of impurities. |
| Keywords: | Omalizumab, Biosimilar, Chromatography, acidic variant, basic variant, high molecular weight variants |
| Cite Article: | "Novel Purification Process Of Omalizumab Biosimilar For Industrial Production", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 6, page no.33 - 40, June-2023, Available :http://www.ijrti.org/papers/IJRTI2306007.pdf |
| Downloads: | 000205320 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2306007
Registration ID:187128
Published In: Volume 8 Issue 6, June-2023
DOI (Digital Object Identifier):
Page No: 33 - 40 Country: Ahmedabad,, Gujarat, India Research Area: Other Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2306007 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2306007 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2025 - All Rights Reserved - IJRTI | |||